Using FAPI PET/MRI to Evaluate Prostate Cancer | stella

Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Using FAPI PET/MRI to Evaluate Prostate Cancer | stella

Back to Prostate Cancer Metastatic Disease trials

Recruiting

Plain-English translation of NCT06675357 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

University of Wisconsin, Madison, Wisconsin

Key details

Phase

Testing effectiveness

Sponsor

University of Wisconsin, Madison

Enrollment target

~30 participants

Started

February 2026

Primary completion

January 2027

Age range

18 Years and older

Last updated on clinicaltrials.gov in June 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Radiology Studies

University of Wisconsin, Madison

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.